Our recent post concerning the adverse (and we thought rather obtuse) SSRI preemption decision in Mason v. SmithKline Beecham drew a response from blog subscriber Mal Wheeler. He was good enough to pass along the letter he recently wrote to the court in the pending Dobbs v. Wyeth SSRI preemption appeal concerning the Mason decision. With his permission, we thought our readers would appreciate the benefits of (some of) Mal’s thoughts about Mason.
